Evidence for a second ankylosing spondylitis-associated <i>RUNX3</i> regulatory polymorphism

Abstract

The association of AS with this <i>RUNX3</i> regulatory region involves at least two SNPs apparently operating in different cell types. Monocytes may be potential therapeutic targets in AS.